INDIAN PESTICIDE APPROVALS UPDATES – MINUTES OF THE 439TH REGISTRATION COMMITTEE (RC) MEETING HELD ON 22.04.2022. The 439th meeting of the Registration…
Patent
-
-
BrazilPatents
INPI Publishes an Update on the Terms of Patent Protection for Pharmaceutical and Non-Pharmaceutical Claims.
by adminby adminSummary: On February 8, 2022, the National Institute of Industrial Property (INPI) published a notice in Gazette 2666 detailing new rules for…
-
Patent LitigationPatents
Seagen Scores $41.8M in Enhertu Patent Case Against Daiichi Sankyo
by adminby adminSummary : A federal jury has awarded biotechnology company Seagen Inc. $41.8 million in a patent infringement lawsuit against Daiichi Sankyo Co.…
-
Active Agrochemical IngredientSpirobudifenTiorantraniliprole
New Agrochemical Discovery Candidates – New ISO Published in 2022 – Spirobudifen (Tetronic acid Acaricide) & Tiorantraniliprole (Diamide insecticides)
by adminby adminNew Agrochemical Discovery Candidates – New ISO Published in 2022 Spirobudifen (Acaricide) & Tiorantraniliprole (Diamide insecticides) April 2022 BCPC – Compendium of…
-
CompaniesIntellectual Property (IP)Patent LitigationPatentsSandoz
Sandoz and Teva Invalidate Patent and SPC of Blockbuster Apixaban
by adminby adminSummary : EP 1,427,415 was assigned to BMS and is set to expire on September 17, 2022. On May 19, 2026, the…
-
437 RC meetingCIBRC - Indian Pesticide ApprovalsRC Meeting updates
INDIA CIBRC UPDATES – MINUTES OF THE 437th REGISTRATION COMMITTEE (RC) MEETING HELD ON 16.03.2022.
by adminby adminMINUTES OF THE 437th REGISTRATION COMMITTEE (RC) MEETING HELD ON 16.03.2022. The 437th meeting of the Registration Committee (RC) was held under…
-
CompaniesModernaPatent LitigationPatentsPfizer
Alnylam Files Patent Infringement Lawsuits Against Pfizer, Moderna
by adminby adminSummary : Alnylam Pharmaceuticals Inc on Thursday filed lawsuits in Delaware federal court against Pfizer Inc and Moderna Inc, claiming their multibillion-dollar…
-
Summary : Endo Pharmaceuticals and Endo Health Solutions, makers of Percocet, Opana, and Percodan, have settled with the State of Florida for…
-
RegulatorySanofi Inc.U.S FDA
Nexviazyme® improves respiration and mobility long-term in Pompe disease patients
by adminby adminSummary : Two-year data shows Pompe disease patients treated with Nexviazyme® (avalglucosidase alfa) have sustained improvements in respiratory function and mobility. Sanofi has…
-
Summary : Alterity Therapeutics have been granted a patent for compounds able to redistribute excess iron in the brain being developed as…